MS: Busting the Myths
April 29, 2024 | Advocacy, Aids, Funding, Life with MS, My Story
Sativex, or Cannabidiol with tetrahydrocannabinol, is an add-on treatment approved by Medsafe for symptom improvement in patients with moderate to severe spasticity due to multiple sclerosis (MS). It is indicated for people who have not responded adequately to other anti-spasticity […]
October 28, 2022
Smokers are more likely to progress from relapsing-remitting to progressive MS than non-smokers and have higher levels of long-term disability. Smokers with clinically isolated syndrome (CIS) are more likely to be diagnosed with MS in the future than non-smokers. Smoking […]